Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

Clinical trial NCT05168930 · RECRUITING

Trial details

NCT number: NCT05168930
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2022-02-18
Primary completion: 2026-10-28
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.